The impact of preoperative biologic therapy on anastomotic complications after surgery for Crohn's disease.
Takayuki
T
Yamamoto
Manabu
M
Shiraki
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D003424:Crohn Disease / Q000601:surgery*; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D059413:Intraabdominal Infections / Q000139:chemically induced*; D008297:Male; D011183:Postoperative Complications / Q000139:chemically induced*; D011239:Prednisolone / Q000009:adverse effects*
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011239:Prednisolone